Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autophagy-related gene LAPTM4B promotes the progression of renal clear cell carcinoma and is associated with immunity. | Front Pharmacol | 2023 | 36937841 | PubTator, text mining | PubMed |
| Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia. | Cancer Immunol Immunother | 2023 | 36932256 | PubTator, text mining | PubMed |
| GWAS meta-analyses clarify the genetics of cervical phenotypes and inform risk stratification for cervical cancer. | Hum Mol Genet | 2023 | 36929174 | PubTator, text mining | PubMed |
| Novel mouse models based on intersectional genetics to identify and characterize plasmacytoid dendritic cells. | Nat Immunol | 2023 | 36928414 | PubTator, text mining | PubMed |
| Research progress on non-protein-targeted drugs for cancer therapy. | J Exp Clin Cancer Res | 2023 | 36918935 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related long noncoding RNA for predicting prognostic and diagnostic value and immune landscape in colorectal adenocarcinoma. | Hum Genomics | 2023 | 36915193 | PubTator, text mining | PubMed |
| Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia. | Nat Biotechnol | 2023 | 36914885 | PubTator, text mining | PubMed |
| AIRE illuminates the feature of medullary thymic epithelial cells in thymic carcinoma. | Cancer Med | 2023 | 36912123 | PubTator, text mining | PubMed |
| Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer. | Cancers (Basel) | 2023 | 36900413 | PubTator, text mining | PubMed |
| The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer. | Cancers (Basel) | 2023 | 36900394 | PubTator, text mining | PubMed |
| CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression. | Cancers (Basel) | 2023 | 36900205 | PubTator, text mining | PubMed |
| Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis. | Front Endocrinol (Lausanne) | 2023 | 36896172 | PubTator, text mining | PubMed |
| Integration of bulk RNA sequencing and single-cell analysis reveals a global landscape of DNA damage response in the immune environment of Alzheimer's disease. | Front Immunol | 2023 | 36895559 | PubTator, text mining | PubMed |
| Cytotoxic CD161-CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. | EBioMedicine | 2023 | 36893588 | PubTator, text mining | PubMed |
| What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis? | Clin Exp Immunol | 2023 | 36883249 | PubTator, text mining | PubMed |
| De-novo reconstruction and identification of transcriptional gene regulatory network modules differentiating single-cell clusters. | NAR Genom Bioinform | 2023 | 36879901 | PubTator, text mining | PubMed |
| Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab. | PLoS One | 2023 | 36877690 | PubTator, text mining | PubMed |
| Translatome analyses by bio-orthogonal non-canonical amino acid labeling reveal that MR1-activated MAIT cells induce an M1 phenotype and antiviral programming in antigen-presenting monocytes. | Front Immunol | 2023 | 36875139 | PubTator, text mining | PubMed |
| Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier. | Front Immunol | 2023 | 36875096 | PubTator, text mining | PubMed |
| The immunotherapy advancement targeting malignant blastomas in early childhood. | Front Oncol | 2023 | 36874100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=42